Name | Bifendate |
Synonyms | Bifendate Bifendatatum Bifendatatum CP BifendatatuM API Biphenyldimethylesterate dimethyl 7,7'-dimethoxy-4,4'-bi-1,3-benzodioxole-5,5'-dicarboxylate 4'-bi-1,3-benzodioxole)-5,5'-dicarboxylicacid,7,7'-dimethoxy-(dimethyles DiMethyl 7,7'-diMethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate dimethyl4,4'-dimethoxy-5,6,5',6'-bis(methylenedioxy)biphenyl-2,2'-dicarboxyl [4,4'-Bi-1,3-benzodioxole]-5,5'-dicarboxylicacid, 7,7'-diMethoxy-, 5,5'-diMethyl ester |
CAS | 73536-69-3 |
EINECS | 1806241-263-5 |
InChI | InChI=1/C20H18O10/c1-23-11-5-9(19(21)25-3)13(17-15(11)27-7-29-17)14-10(20(22)26-4)6-12(24-2)16-18(14)30-8-28-16/h5-6H,7-8H2,1-4H3 |
Molecular Formula | C20H18O10 |
Molar Mass | 418.35 |
Density | 1.390±0.06 g/cm3(Predicted) |
Melting Point | 179-181 °C |
Boling Point | 606.9±55.0 °C(Predicted) |
Flash Point | 265.9°C |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Vapor Presure | 1.12E-14mmHg at 25°C |
Appearance | Solid |
Color | White to Off-White |
Storage Condition | 2-8°C(protect from light) |
Refractive Index | 1.579 |
MDL | MFCD01751431 |
Use | Anti-hepatitis drugs for the treatment of chronic persistent hepatitis, chronic active hepatitis and other diseases |
Reference Show more | 1. [IF=3.205] Zhibin Wang et al."Simultaneous determination of cucurbitacin B and cucurbitacin E in rat plasma by UHPLC-MS/MS: A pharmacokinetics study after oral administration of cucurbitacin tablets."J Chromatogr B. 2017 Oct;1065-1066:63 |